Research Protocol Builder
Build Your Peptide Stack
Select a research goal below to see the recommended peptide combination, dosing protocol, and visual timeline.
Fat Loss & Metabolic Health
A research protocol targeting metabolic rate, lipolysis, and insulin sensitivity. Retatrutide (triple GLP-1/GIP/glucagon agonist) anchors the stack; AOD-9604 drives direct lipolysis via β3-adrenergic pathways; 5-Amino-1MQ inhibits NNMT to elevate NAD+ and metabolic rate; NAD+ injectable supports mitochondrial function and DNA repair.
| Route | SubQ injection |
| Frequency | Once weekly |
| Titration Schedule | |
| Wks 1–4 | 0.5 mg/week (tolerance) |
| Wks 5–8 | 1 mg/week |
| Wks 9–12 | 2 mg/week |
| Taper (do not stop abruptly) | |
| Wks 13–14 | 1 mg/week |
| Wks 15–16 | 0.5 mg/week |
| Dose | 300 mcg |
| Route | SubQ injection |
| Frequency | Daily (AM, fasted) |
| Duration | Weeks 1–12 |
| Dose | 50–100 mg |
| Route | Oral |
| Frequency | Daily |
| Duration | Weeks 1–12 |
| Dose | 250–500 mg |
| Route | SubQ injection |
| Frequency | 3× / week |
| Duration | Weeks 1–12 |
Healing & Recovery
The most widely researched peptide combination for tissue repair. BPC-157 promotes local angiogenesis and fibroblast migration; TB-500 drives systemic actin regulation and cell migration; GHK-Cu reduces inflammation and stimulates collagen synthesis. Available as individual peptides or as a convenient blend.
| Dose | 250–500 mcg |
| Route | SubQ injection |
| Frequency | Daily |
| Duration | Weeks 1–8 |
| Route | SubQ injection |
| Loading Phase (Wks 1–2) | |
| Dose | 5 mg, 2× / week |
| Maintenance (Wks 3–8) | |
| Dose | 2.5 mg, 2× / week |
| Dose | 1–2 mg |
| Route | SubQ injection |
| Frequency | Daily |
| Duration | Weeks 3–8 |
Muscle Growth & Performance
A growth hormone secretagogue stack combined with recovery peptides. CJC-1295 NO DAC and Ipamorelin work synergistically to pulse GH release, while BPC-157 and TB-500 support connective tissue integrity under high training loads. Run as a 12-week active cycle followed by a 4-week off-cycle break before repeating. Available as individual peptides or using our pre-combined blends.
| Dose | 100–200 mcg |
| Route | SubQ injection |
| Frequency | Daily (pre-sleep) |
| Duration | Weeks 1–12 |
| Cycle Guidance | |
| 12 weeks on → 4 weeks off. Do not taper — stop cleanly at end of cycle. | |
| Dose | 200–300 mcg |
| Route | SubQ injection |
| Frequency | Daily (pre-sleep) |
| Duration | Weeks 1–12 |
| Cycle Guidance | |
| Always pair with CJC-1295 NO DAC. 12 weeks on → 4 weeks off. | |
| Dose | 250 mcg |
| Route | SubQ injection |
| Frequency | Daily |
| Duration | Weeks 1–12 |
| Dose | 2 mg |
| Route | SubQ injection |
| Frequency | 2× / week |
| Duration | Weeks 1–8 |
Longevity & Anti-Aging
A telomere-focused and immune-modulating protocol. Epithalon is the most studied peptide for telomerase activation; NAD+ supports mitochondrial function and DNA repair; MOTS-C addresses metabolic senescence; Thymosin Alpha-1 modulates immune function and thymic activity.
| Dose | 5–10 mg |
| Route | SubQ injection |
| Frequency | Daily × 10 days (cycle) |
| Duration | Weeks 1–2, 6–7 |
| Dose | 250–500 mg |
| Route | SubQ injection |
| Frequency | 3× / week |
| Duration | Weeks 1–10 |
| Dose | 5–10 mg |
| Route | SubQ injection |
| Frequency | 3× / week |
| Duration | Weeks 1–10 |
| Dose | 1.6 mg |
| Route | SubQ injection |
| Frequency | 2× / week |
| Duration | Weeks 1–10 |
Cognitive Performance
A nootropic peptide protocol targeting BDNF upregulation, dopamine modulation, and stress-axis regulation. Semax drives BDNF and cognitive enhancement; Selank provides anxiolytic and focus-enhancing effects via GABAergic modulation; DSIP (Delta Sleep-Inducing Peptide) supports deep sleep architecture for optimal cognitive recovery.
| Route | Intranasal |
| Frequency | Daily (AM) |
| Titration | |
| Wk 1 | 100 mcg/day (tolerance) |
| Wks 2–4 | 200–300 mcg/day |
| Cycle Guidance | |
| 4 weeks on → 2 weeks off. No taper needed. | |
| Dose | 250–500 mcg |
| Route | Intranasal |
| Frequency | Daily (AM) |
| Duration | Weeks 1–4 |
| Cycle Guidance | |
| 4 weeks on → 2 weeks off. Can be used alongside Semax. | |
| Dose | 100–200 mcg |
| Route | SubQ injection |
| Frequency | 3× / week (pre-sleep) |
| Duration | Weeks 1–4 |
| Cycle Guidance | |
| 4 weeks on → 2 weeks off. Use during active Semax/Selank cycle for synergistic recovery. | |